Inventor · disambiguated record
Rodolphe Obeid
Also filed as: OBEID RODOLPHE
13 granted patents·18 pending applications·50 citations·filing 2014–2024
90Inventor score
Files withINTELGENX CORP31
Top patents by PatentIndex Score
31 records- 0194US10272038B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2017·Granted Apr 30, 2019·9 cites·28 claims
- 0293US11471406B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2020·Granted Oct 18, 2022·3 cites·20 claims
- 0392US9668970B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2014·Granted Jun 6, 2017·11 cites·20 claims
- 0490US11033493B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2018·Granted Jun 15, 2021·5 cites·20 claims
- 0590US10828254B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2018·Granted Nov 10, 2020·4 cites·20 claims
- 0689US10722476B2Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2018·Granted Jul 28, 2020·3 cites·12 claims
- 0788US11602504B2Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Granted Mar 14, 2023·4 cites·17 claims
- 0886US9949934B1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2016·Granted Apr 24, 2018·5 cites·3 claims
- 0985US11648212B2Loxapine film oral dosage formINTELGENX CORP·Filed 2018·Granted May 16, 2023·3 cites·12 claims
- 1083US10610528B2Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2017·Granted Apr 7, 2020·3 cites·10 claims
- 1183US2025120908A1Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2024·Application pending·0 cites
- 1279US12156937B2Oral film formulation for modulating absorption profileINTELGENX CORP·Filed 2022·Granted Dec 3, 2024·0 cites·20 claims
- 1372US2023201130A1Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2023·Application pending·0 cites
- 1468US2023248660A1Method of preparing loxapine film oral dosage formINTELGENX CORP·Filed 2023·Application pending·0 cites
- 1567US11957785B2Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2021·Granted Apr 16, 2024·0 cites·20 claims
- 1667US2022362164A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 1767US2022395452A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2022·Application pending·0 cites
- 1866US2019247505A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2019·Application pending·0 cites
- 1962US2019209459A1Film dosage form with extended release mucoadhesive particlesINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2061US2019290595A1Device and method of treating conditions associated with neuroinflammationINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2159US2019133925A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 2258US2018250240A1Method of treatment and device for the improved bioavailability of leukotriene receptor antagonistsINTELGENX CORP·Filed 2018·Application pending·0 cites
- 2357US2016324773A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2016·Application pending·0 cites
- 2455US12303501B2Lipophilic active oral film formulation and method of making the sameINTELGENX CORP·Filed 2019·Granted May 20, 2025·0 cites·20 claims
- 2554US2016243036A1Film dosage forms containing amorphous active agentsINTELGENX CORP·Filed 2015·Application pending·0 cites
- 2654US2020215063A1Solid oral film dosage forms and methods for making sameINTELGENX CORP·Filed 2020·Application pending·0 cites
- 2749US2019314293A1Loxapine film oral dosage formINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2849US2019231685A1Antihistamine oral film dosage form and method of administrating sameINTELGENX CORP·Filed 2019·Application pending·0 cites
- 2945US2018110724A1Film dosage form with multimodal and particle size distributionsINTELGENX CORP·Filed 2017·Application pending·0 cites
- 3040US2017216220A1Loxapine film oral dosage formINTELGENX CORP·Filed 2016·Application pending·0 cites
- 3136US2017258710A1Montelukast transmucosal filmINTELGENX CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rodolphe Obeid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →